HER2 Support Group Forums - View Single Post - Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis s

News · 02-19-2018, 02:44 AM

Myriad Genetics, Inc. today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage breast cancer has been published in JAMA Oncology.

More...

02-19-2018, 02:44 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,981	Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis s Myriad Genetics, Inc. today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage breast cancer has been published in JAMA Oncology. More...